-
The Opportunity Cost of Waiting
A recent report published by Harvard Medical School highlighted the following patient cost in attending a medical appointment:Total time involvement….121 minutes; which broke down to Travel time….37 minutes and Clinic time……84 minutes. Within the clinic time segment, only 20 minutes was spent with the doctor. Those figures, extrapolated to represent the entire US population amounted to […]
-
Methods for gaining knowledge – mentors, advisers and choosing a discomfort zone
I was reading up on some material written by marketing guru Seth Godin and marveled once more at the insight this man brings to his writing so effortlessly and at once, so obvious as to wonder why you hadn’t tapped the same vein of thought through your own resources. He highlights that if we go […]
-
Four trends that will drive future health policy – PGA analysis
A recent bulletin was issued by the Pharmacy Guild of Australia (PGA) that gave an insight into the thinking behind the 7CPA preparation that will commence shortly. i2P thought that this would be an excellent point in time to contribute comment in a constructive manner. Hopefully a “think-tank” process may evolve where input can be […]
-
The Perfect Prescription
In the world of pharmacy we have evolved from basically a practice that dealt in compounded prescriptions of herbal substances at an affordable cost to a plethora of synthetic drugs supported by dubious evidence. And it has happened in my lifetime. My query is that if we have a situation where so-called solid evidence exists […]
-
Avatars May Take Over Patient Communications – Where to from there?
Global Pharma’s are known to be funding the development of systems to deal directly with patients. These systems will involve the use of Artificial Intelligence and the use of Volumetric 3D immersion technologies. The former will allow delivery of technical information through well modulated voice transmission, while the latter will provide an “avatar” transformed from […]
-
Boots Accused of Profiteering Over Professionalism
Boots has been accused of boosting its profits by forcing staff to abuse an NHS scheme intended to help sick patients. Managers at Britain’s biggest pharmacy chain were found to be directing their pharmacists to provide medicine-use reviews (MUR’s) to patients who didn’t need them, in order to claim public money from the NHS. The NHS […]
-
Switzerland Gets it Right
Switzerland is a country known for its precision and its ability to keep its transport system “on time”. It is a landlocked country so when it decides how it could survive, it basically chose financial services and manufacturing industries that are “light” in weight but high value. Drug manufacture fitted that requirement, as was watch-making. […]
-
VAXXED – From Cover-Up to Catastrophe
The writers at i2P have always had knowledge of the links between Big Pharma, Big Agriculture, Big Tobacco and mainstream media. Big Pharma has major investments in mainstream media and entertainment enterprises. It also includes Hollywood and its actors, plus the music industry and sporting organisations. That Big Pharma can practice its character assassination through its […]
-
Increase Safety Checks as Pharmacists Prepare to Leave Dispensaries
With the introduction of automated dispensing systems new safety factors appear as the pharmacist has to interface and change work-flows between dispensing assistants and the patient. And that takes place after a complete refit of the dispensary to accommodate the new robotic equipment and its impact on work-flows. Because of the pressures on the pharmacist […]
-
Understanding the Impacts of a Global Pharmacy Invasion
Recently, i2P ran some articles postulating the expansion strategies of global supermarket and pharmacy groups. It is a story of consolidation of the pharmacy industry, both horizontally and vertically to form up massive conglomerates that concentrate purchasing power and market share of retail pharmacy goods and services. And it is a story that is mostly […]